We are live on ! Find out more
PRAX icon

Praxis Precision Medicines
PRAX

86 hedge funds and large institutions have $43.1M invested in Praxis Precision Medicines in 2023 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 39 increasing their positions, 19 reducing their positions, and 29 closing their positions.

New
Increased
Maintained
Reduced
Closed

105% more repeat investments, than reductions

Existing positions increased: 39 | Existing positions reduced: 19

50% more funds holding in top 10

Funds holding in top 10: 2 → 3 (+1)

0.35% more ownership

Funds ownership: 6.43% → 6.77% (+0.35%)

17% less funds holding

Funds holding: 103 → 86 (-17)

59% less first-time investments, than exits

New positions opened: 12 | Existing positions closed: 29

60% less capital invested

Capital invested by funds: $108M → $43.1M (-$64.7M)

92% less call options, than puts

Call options by funds: $17K | Put options by funds: $204K

Holders
86
Holders Change
-17
Holders Change %
-16.5%
% of All Funds
1.37%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.05%
New
12
Increased
39
Reduced
19
Closed
29
Calls
$17K
Puts
$204K
Net Calls
-$187K
Net Calls Change
-$191K

Top Buyers

1
VCIM
Velan Capital Investment Management
Georgia
+$14.6M
2
APM
Avidity Partners Management
Texas
+$12M
3
Bank of America
Bank of America
North Carolina
+$7.07M
4
TLP
Tri Locum Partners
New York
+$6.93M
5
GPP
Great Point Partners
Connecticut
+$5.72M

Top Sellers

1
Blackstone Inc
Blackstone Inc
New York
-$10.8M
2
EAM
Eventide Asset Management
Massachusetts
-$8.37M
3
EC
EcoR1 Capital
California
-$3.77M
4
AG
Artal Group
Luxembourg
-$2.86M
5
OCA
Octagon Capital Advisors
New York
-$1.9M
Name Holding Trade Value Shares
Change 		Change in
Stake
Northern Trust
26
Northern Trust
Illinois
$329K +$153K +3,622 +15%
Federated Hermes
27
Federated Hermes
Pennsylvania
$314K +$54.4K +1,289 +5%
Renaissance Technologies
28
Renaissance Technologies
New York
$307K +$45K +1,066 +4%
Marshall Wace
29
Marshall Wace
United Kingdom
$230K +$798K +18,913 New
Los Angeles Capital Management
30
Los Angeles Capital Management
California
$213K +$370K +8,770 +99%
Dimensional Fund Advisors
31
Dimensional Fund Advisors
Texas
$200K +$367K +8,691 +111%
Millennium Management
32
Millennium Management
New York
$142K +$24.6K +584 +5%
Two Sigma Advisers
33
Two Sigma Advisers
New York
$139K -$776K -18,387 -62%
BCM
34
Bridgeway Capital Management
Texas
$126K +$119K +2,814 +37%
N
35
Nuveen
North Carolina
$124K -$108K -2,550 -20%
JGC
36
J. Goldman & Co
New York
$109K +$380K +9,000 New
Charles Schwab
37
Charles Schwab
California
$105K +$53.3K +1,262 +17%
Bank of New York Mellon
38
Bank of New York Mellon
New York
$103K +$23K +545 +7%
RJA
39
Raymond James & Associates
Florida
$93.5K – – –
Susquehanna International Group
40
Susquehanna International Group
Pennsylvania
$84.4K +$237K +5,608 +416%
PI
41
PEAK6 Investments
Illinois
$72.4K +$252K +5,965 New
AllianceBernstein
42
AllianceBernstein
Tennessee
$65.3K – – –
TCM
43
Tekla Capital Management
Massachusetts
$60.7K – – –
AQR Capital Management
44
AQR Capital Management
Connecticut
$60.3K -$242K -5,729 -54%
CIC
45
Cornercap Investment Counsel
Georgia
$59.2K +$422 +10 +0.2%
BFM
46
Boothbay Fund Management
New York
$57.6K +$129K +3,046 +179%
RhumbLine Advisers
47
RhumbLine Advisers
Massachusetts
$51K +$22.2K +527 +14%
SFI
48
Susquehanna Fundamental Investments
Pennsylvania
$50.4K – – –
Two Sigma Investments
49
Two Sigma Investments
New York
$42.7K -$636K -15,065 -81%
Point72 Asset Management
50
Point72 Asset Management
Connecticut
$40.5K -$141K -3,334 -50%
1
2
3 4 5

PRAX Hedge Fund Activity: Q1 2023 in Review

86 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in Praxis Precision Medicines (PRAX) for Q1 2023, worth a combined $43.1M — down 60% from $108M a quarter earlier.

Sellers outnumbered buyers: 29 funds closed out of PRAX and 12 opened new positions — a net loss of 17 holders — while 19 trimmed existing stakes and 39 added.

The largest buyer was Velan Capital Investment Management, opening a new position worth an estimated $14.6M. The largest seller was Blackstone Inc, cutting an estimated $10.8M.

  • 86 institutional investors held Praxis Precision Medicines (PRAX) as of Q1 2023, down from 103 in Q4 2022.
  • Funds reported $43.1M of Praxis Precision Medicines stock for Q1 2023, down 60% quarter-over-quarter.
  • 12 funds opened new Praxis Precision Medicines positions in Q1 2023 and 29 closed out, a net change of -17 holders.
  • The largest Praxis Precision Medicines buyer in Q1 2023 was Velan Capital Investment Management, an estimated $14.6M added.
  • The largest Praxis Precision Medicines seller in Q1 2023 was Blackstone Inc, an estimated $10.8M sold.

Based on aggregated 13F filings for Q1 2023.